Search Results - Endovascular Today

evt | Article | May 2018

BTK Device Selection: Crossing Tools

Choosing the appropriate technique to achieve good outcomes in challenging infrapopliteal lesions.

By Osamu Iida, MD; Yosuke Hata, MD; and Toshiaki Mano, MD, PhD

evt | Article | August 2013

Pharmacologic Options for Treating Restenosis

The role of cilostazol in the treatment of patients with infrainguinal lesions.

By Osamu Iida, MD, and Yoshimitsu Soga, MD

evt | Article | September 2010

The Angiosome Concept

A look at how this concept is being used to treat patients with critical limb ischemia.

By Osamu Iida, MD; Masaaki Uematsu, MD, PhD; and Hiroto Terashi, MD, PhD

evt | Article | September 2020

The Role of Intravascular Ultrasound in the Endovascular Treatment of Femoropopliteal Artery Lesions

How IVUS can be used to collect and analyze data on vessel and lesion characteristics to influence the success of femoropopliteal treatment.

By Osamu Iida, MD; Yosuke Hata, MD; and Naoya Kurata, BHS

evt | Article | October 2016

Ask the Experts: What SFA Trials Would You Most Like to See?

Experts discuss key questions to answer, potential trial designs, and the likelihood that the trials will be undertaken.

With Peter A. Schneider, MD; Thomas Zeller, MD; Osamu Iida, MD; Marianne Brodmann, MD; Krishna Rocha-Singh, MD; and Christopher Metzger, MD

evt | Article | November 2025

The Aperta Novel Scoring Element for the Treatment of Complex PAD

Enhanced angioplasty with focal force technology now offers a proven path to achieving more effective and durable results.

With Craig Walker, MD; Matthew T. Finn, MD, MSc; Yoshiteru Okina, MD; and Osamu Iida, MD

evt | News | July 19, 2009

Effect of Femoropopliteal Stent Fracture on Patency Studied

July 20, 2009—In the Journal of the American College of Cardiology: Cardiovascular Interventions, Osamu Iida, MD, et al published findings from their investigation of the time course of stent patency in the femoropopliteal artery for as long as 4 years (2009;2:665–671).

evt | Article | May 2019

Ask the Experts: What Is Your Top Tip on How to Safely and Efficiently Cross a Lower Extremity CTO?

Experts discuss their access approaches to and techniques for crossing chronic total occlusions.

With John A. Phillips, MD; Saher Sabri, MD, FSIR; Ramon L. Varcoe, MBBS, MS, FRACS, PhD; Sabine Steiner, MD; and Osamu Iida, MD

evt | News | September 21, 2015

Three-Year Outcomes of the Japanese OLIVE Registry Published

September 22, 2015—The 3-year follow-up results of the OLIVE registry were published by Osamu Iida, MD, et al in the Journal of the American College of Cardiology (JACC): Cardiovascular Interventions (2015;8:1493–1502).

evt | Article | September 2024

Drug Delivery From ATK to BTK: What Is on the Horizon?

Experts discuss differences in drug delivery between ATK and BTK, the future of sirolimus-coated balloons, device innovation in the infrapopliteal arteries, where drug-eluting bioresorbable scaffolds fit into the BTK algorithm, and the most significant unmet needs.

With moderator Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed(ClinEpi), and panelists Marianne Brodmann, MD; Osamu Iida, MD, PhD; Sahil A. Parikh, MD; and Peter A. Schneider, MD

evt | News | February 8, 2017

Medtronic's Drug-Coated Balloon Evaluated in the IN.PACT SFA Japan Trial

February 9, 2017—Medtronic announced that the 1-year clinical outcomes from the MDT-2113 IN.PACT SFA Japan trial were presented by Osamu Iida, MD, at LINC 2017, the Leipzig Interventional Course, which was held January 24–27 in Leipzig, Germany.

evt | News | January 31, 2018

Presentations Support Medtronic's In.Pact Admiral Drug-Coated Balloon

January 30, 2018—Medtronic announced that clinical data supporting the company's In.Pact Admiral drug-coated balloon (DCB) were presented at LINC 2018: the Leipzig Interventional Course held January 30 to February 2 in Leipzig, Germany.

evt | News | October 31, 2023

Gore Viabahn Studied for Treatment of Complex Femoropopliteal Lesions in a Japanese Population

October 31, 2023—Five-year outcomes were presented from a study to assess safety and effectiveness of the Viabahn endoprosthesis (Gore & Associates) for the treatment of symptomatic lower extremity arterial disease (LEAD) in complex femoropopliteal (FP) lesions in a Japanese population.

evt | Article | May 2018

CLI: Emerging Concepts in Care

By Jos C. van den Berg, MD, PhD, and Jihad A. Mustapha, MD, FACC, FSCAI

evt | News | September 7, 2017

Medtronic's In.Pact Admiral DCB Approved in Japan

September 8, 2017—Medtronic announced that its In.Pact Admiral drug-coated balloon (DCB) received approval from the Japanese Ministry of Health, Labor, and Welfare (MHLW) for the treatment of peripheral artery disease (PAD) in the superficial femoral arteries (SFAs) and popliteal arteries.

evt | Article | September 2024

Evolving PAD Approaches

By Peter A. Schneider, MD

evt | News | January 16, 2025

Concept Medical’s MAGICAL BTK IDE Trial Begins Enrollment

January 16, 2025—Concept Medical Inc., announced the enrollment of the first patient in the pivotal MAGICAL BTK randomized controlled trial, which is being conducted in the United States under an FDA-approved investigational device exemption (IDE).

evt | News | May 30, 2023

MedAlliance SELUTION SFA Trial in Japan Reveals 12-Month Results

May 30, 2023—MedAlliance announced 12-month results from the prospective, multicenter, single-arm SELUTION SFA trial, which sought to assess the safety and efficacy of the company’s Selution SLR sirolimus-eluting balloon for endovascular therapy of de novo and nonstented restenotic lesions in the superficial femoral artery (SFA) and popliteal artery.

evt | Article | September 2010

CHIEF MEDICAL EDITOR'S PAGE

Improving CLI Patient Care

By John R. Laird Jr, MD,